Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes.
Jones GM, Nock MK
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (0)
No references identified in the available metadata. This does not establish that none exist.
Cited by — these papers cite this paper (3)
- Prevalence and Correlates of Past-Year Psilocybin Use in the United States 2026-11-01 · Expand citations
- Psilocybin and Mental Health Outcomes: Scoping Review with ☸️SAIMSARA 2026-06-15 · Expand citations
- Addressing a major interference in the quantification of psilocin in mouse plasma: Development of a validated liquid chromatography tandem mass spectrometry method 2024-08-01 · Expand citations